Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
No payment upfront you only pay when your prescription is approved
The cerebello-thalamo-cortical loop is already implicated in the pathogenesis of ataxia, a clinical sign that is frequently comorbid with tremor
Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
The FDA convened the committee meeting on July 23 and 24 to debate whether to recommend that seven popular peptides be included on a list, called the 503A bulks list, that would allow compounding pharmacies to dispense them
US$ 24.53
US$ 29.58
US$ 27.14
